Canada Ceases Funding to International AIDS Vaccine Project

.

International AIDS Vaccine Initiative

As per the latest budget, the Federal Government is revealed to have stopped funding the International AIDS Vaccine Initiative (IAVI) through Canadian International Development Agency (CIDA) grants.

Between 2001 and 2008, the Canadian International Development Agency reportedly funded nearly $80 million to the International AIDS Vaccine Initiative, one of the biggest supporters of HIV vaccine trials in the world. Canada was one of IAVI's major funders.

"IAVI was informed in July 2009 that CIDA funding priorities are under review, and that no further commitments could be made at that time", an IAVI spokeswoman told the Winnipeg Free Press.

The Government's cancellation of plans is revealed to emerge with a view to develop a vaccine production facility as part of the Canadian HIV Vaccine Initiative (CHVI) in partnership with the Bill and Melinda Gates Foundation.

Stephen Lewis, co-Director of AIDS Free World in the U. S. and former UN Special Envoy for HIV/AIDS in Africa, reveal that now, the global AIDS research community is aware of the fact that Canada can't be counted on to help.

Health Minister Leona Aglukkaq and Public Health chief Dr. David Butler-Jones have insisted that they are in an examination process, pondering over all possible options required to effectively spend CHVI money.


Latest News

Brazilian President Says Growth in the U.S. Could Result in an Improvement of Br
Anonymous Whistleblower to get $30 Million from SEC
Siemens Plans to Acquire Dresser-Rand for $6 billion Says Sources
OSI Group to Cut 340 Jobs in China in Relation to Food Safety Scandal
PARK(ing) Day Celebration Turns Parking Spots into Temporary Parks
Oasis Beverages a Russian Company Buys Pabst
About 6.4 trillion calories to be cut from food products
Rise in sexually transmitted infections worry all
Breast cancer awareness taken to another level by foundation
Practicing yoga can help bipolar disorder
Oracle’s Chief Larry Ellison Retires
Price of Alibaba IPO Remains at Top Range